Showing 1901-1910 of 8649 results for "".
- BVI Introduces Patient Packs Aimed at Helping US Ophthalmologists Bring Patients Backhttps://modernod.com/news/bvi-introduces-patient-packs-aimed-at-helping-us-ophthalmologists-bring-patients-back/2478280/BVI has released a line of Patient Packs to help US ophthalmologists bring patients back to the office and OR with confidence, according to a company news release. Ophthalmologists are seeking to get back to normal and address the backlog of patients whose vision has been negatively impact
- Gilead Files For US Approval of Veklury to Treat COVID-19https://modernod.com/news/gilead-files-for-us-approval-of-veklury-to-treat-covid-19/2478148/Gilead Sciences that it has submitted an application to the FDA seeking approval of its experimental antiviral Veklury (remdesivir) as a treatment for patients with COVID-19. The drug is currently available in the US under an emergency-use authorization for hospitalized patients severely il
- Accelmed Partners Completes Acquisition of TearLabhttps://modernod.com/news/accelmed-partners-completes-acquisition-of-tearlab/2477991/Private equity firm Accelmed Partners II (AP-II) completed its $25 million acquisition of dry eye device maker TearLab. As a newly formed private company, TearLab is now positioned to pursue further development of its next-generation Discovery platform and seek out targeted acquisition opp
- Novartis Withdraws Marketing Application of Dry Eye Drug Xiidra in Europehttps://modernod.com/news/novartis-pulls-eu-filing-seeking-approval-of-xiidra-for-dry-eye-disease/2477942/Novartis has decided to withdraw its marketing application seeking approval of dry eye drug Xiidra (lifitegrast) in Europe. The decision comes after the European Medicines Agency (EMA) said the drug’s benefits did not outweigh its risks. Novartis pulled the application on June 18 after the
- Novartis Harnessing AI in Amazon Partnership Aimed at Revamping Drug Manufacturing, Supplyhttps://modernod.com/news/novartis-harnessing-ai-in-amazon-partnership-aimed-at-revamping-drug-manufacturing-supply/2477142/Novartis announced Wednesday that it will work with Amazon’s cloud-computing unit to build a data and analytics platform that seeks to “re-invent” the way medicines are manufactured and delivered. “Four years ago, we started our journey with AWS (Amazon Web Servi
- Fight For Sight and Prevent Blindness Announce Call for Entries for the 2020 Joanne Angle Public Health Awardhttps://modernod.com/news/fight-for-sight-and-prevent-blindness-announce-call-for-entries-for-the-2020-joanne-angle-public-health-award/2476933/National non-profit organizations Fight for Sight and Prevent Blindness are announcing a call for applications for the Joanne Angle Public Health Award, a $25,000 grant to support a public health research project seeking to put an end to unnecessary vision loss. The award was named for Ms
- FDA Does Not Approve Bausch Health, Eton’s Pharma’s EM-100 for Allergic Conjunctivitishttps://modernod.com/news/fda-does-not-approve-bausch-health-etons-pharmas-em-100-for-allergic-conjunctivitis/2476731/Eton Pharmaceuticals on Friday said that partner Bausch Health Companies has received a complete response letter from the FDA for its filing seeking approval of the investigational therapy EM-100 to treat ocular itching associated with allergic conjunctivitis. “We
- Jury Awards Allergan Just $48,500 in Trial Over Imprimis False Adshttps://modernod.com/news/jury-awards-allergan-just-48500-in-trial-over-imprimis-false-ads/2476595/A California federal jury ordered Imprimis Pharmaceuticals to pay Allergan for lost profits due to false advertising of its compounded drugs. However, the jury awarded just $48,500 in damages, a small fraction of the millions of dollars that Allergan was seeking. According to a
- CooperVision Forum Gathers Global Experts in Childhood Myopia, Identifies Improved Opportunities to Assess and Manage the Conditionhttps://modernod.com/news/coopervision-forum-gathers-global-experts-in-childhood-myopia-identifies-improved-opportunities-to-assess-and-manage-the-condition/2479685/A distinguished panel of global authorities in myopia management gathered this week in Texas, on the eve of the American Academy of Optometry (AAOptom) annual meeting, seeking ways to help eye care professionals better assess and manage the growing epidemic among children. The Myopia Management E
- Pennsylvania Senate Approves Bill That Would Expand Optometrists’ Scope of Practicehttps://modernod.com/news/pennsylvania-senate-approves-bill-that-would-expand-optometrists-scope-of-practice/2479790/A Pennsylvania bill – Senate Bill (SB) 668, introduced by Sen. John Gordner – seeks to expand optometrists’ scope of practice beyond the limits of their training. The bill passed the full Senate by a vote of 32-17 on Sept. 25, 2018, and it now awaits consideration by the House Professional Licens